Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell developmentAndrea M Woltman, Catherine Massacrier, Johan W de Fijter, et al.
Oncoimmunology|June 27, 2013
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4<sup>+</sup> T cells by plasmacytoid dendritic cellsJulien Faget, Vanja Sisirak, Jean-Yves Blay, et al.
Frontiers in Immunology|June 28, 2019
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell FunctionSelena Vigano, Dimitrios Alatzoglou, Melita Irving, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
Cancers|October 14, 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid CancersYasmine Lounici, Olivia Le Saux, Gabriel Chemin, et al.
Oncoimmunology|March 14, 2013
Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3<sup>+</sup> regulatory T cells and are associated with poor prognosis in breast cancer patientsVanja Sisirak, Julien Faget, Nelly Vey, et al.
Blood|January 15, 2005
Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responsesEstelle Merck, Blandine de Saint-Vis, Mathieu Scuiller, et al.
Journal of Immunology Research|December 15, 2015
In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-SpacerBéatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, et al.
Frontiers in Immunology|February 26, 2019
Cold Tumors: A Therapeutic Challenge for ImmunotherapyPaola Bonaventura, Tala Shekarian, Vincent Alcazer, et al.
European Journal of Immunology|January 10, 2002
Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfacesBéatrice Vanbervliet, Bernhard Homey, Isabelle Durand, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell developmentAndrea M Woltman, Catherine Massacrier, Johan W de Fijter, et al.
Oncoimmunology|June 27, 2013
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4<sup>+</sup> T cells by plasmacytoid dendritic cellsJulien Faget, Vanja Sisirak, Jean-Yves Blay, et al.
Frontiers in Immunology|June 28, 2019
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell FunctionSelena Vigano, Dimitrios Alatzoglou, Melita Irving, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
Cancers|October 14, 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid CancersYasmine Lounici, Olivia Le Saux, Gabriel Chemin, et al.
Oncoimmunology|March 14, 2013
Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3<sup>+</sup> regulatory T cells and are associated with poor prognosis in breast cancer patientsVanja Sisirak, Julien Faget, Nelly Vey, et al.
Blood|January 15, 2005
Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responsesEstelle Merck, Blandine de Saint-Vis, Mathieu Scuiller, et al.
Journal of Immunology Research|December 15, 2015
In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-SpacerBéatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, et al.
Frontiers in Immunology|February 26, 2019
Cold Tumors: A Therapeutic Challenge for ImmunotherapyPaola Bonaventura, Tala Shekarian, Vincent Alcazer, et al.
European Journal of Immunology|January 10, 2002
Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfacesBéatrice Vanbervliet, Bernhard Homey, Isabelle Durand, et al.
Pageof 15